Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA
Public ClinicalTrials.gov record NCT02814916. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Open-Label, Randomized, Comparator Controlled Trial of the Safety and Efficacy of Dalbavancin Versus Active Comparator in Pediatric Subjects With Acute Bacterial Skin and Skin Structure Infections
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To determine the safety and descriptive efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections in children, aged birth to 17 years (inclusive), known or suspected to be caused by susceptible Gram-positive organisms, including methicillin-resistant strains of Staphylococcus aureus.
Study identification
- NCT ID
- NCT02814916
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 199 participants
Conditions and interventions
Conditions
Interventions
- Dalbavancin Drug
- Vancomycin Drug
- Oxacillin Drug
- Flucloxacillin Drug
- Cefadroxil Drug
- Clindamycin Drug
Drug
Eligibility (public fields only)
- Age range
- 0 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 30, 2017 (Actual)
- Primary completion
- Jan 1, 2024 (Actual)
- Completion
- Jan 1, 2024 (Actual)
- Last update posted
- Sep 19, 2024
2017 – 2024
United States locations
- U.S. sites
- 15
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of South Alabama /ID# 237446 | Mobile | Alabama | 36604-3302 | — |
| Valleywise Health Medical Center /ID# 234343 | Phoenix | Arizona | 85008-4973 | — |
| Southbay Pharma Research /ID# 235700 | La Palma | California | 90623 | — |
| University of California, Los Angeles /ID# 237533 | Los Angeles | California | 90095 | — |
| Duplicate_Children's Hospital Colorado /ID# 237622 | Aurora | Colorado | 80045 | — |
| Global Research Holdings LLC /ID# 235747 | Panama City | Florida | 32405 | — |
| Tampa General Hospital /ID# 237061 | Tampa | Florida | 33606 | — |
| Children's Healthcare of Atlanta - Ferry Rd /ID# 237003 | Atlanta | Georgia | 30342-1605 | — |
| University of Maryland Medical Center /ID# 234353 | Baltimore | Maryland | 21201-1544 | — |
| Duplicate_Children's Mercy Hospital and Clinics /ID# 237800 | Kansas City | Missouri | 64108 | — |
| Robert Wood Johnson Univ Hosp /ID# 237862 | New Brunswick | New Jersey | 08901 | — |
| NYU School of Medicine /ID# 236783 | New York | New York | 10016 | — |
| SUNY Upstate Medical University /ID# 236831 | Syracuse | New York | 13210 | — |
| Duke University Medical Center /ID# 234315 | Durham | North Carolina | 27705-4410 | — |
| Cleveland Clinic Main Campus /ID# 237564 | Cleveland | Ohio | 44195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 69 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02814916, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 19, 2024 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02814916 live on ClinicalTrials.gov.